DE:30S Stock Latest News
Company AnnouncementsSaniona Names Nomination Committee for 2027 AGM5h ago
Company AnnouncementsSaniona Gains Capital-Raising Authority as Option Plan Withdrawn1d ago
Company AnnouncementsSaniona Files IND for Rapid-Acting Depression Drug SAN24652w ago
Company AnnouncementsSaniona advances SAN2465 as oral rapid-acting antidepressant with new preclinical data3w ago- Company AnnouncementsSaniona maps out busy 2026 conference schedule to showcase neurology pipeline3w ago
Company AnnouncementsSaniona Calls Extraordinary Meeting to Seek Fresh Issuance Mandate3w ago
Company AnnouncementsSaniona Schedules Q2 Investor Call for 27 August 20262M ago
Company AnnouncementsAstronauTx Takes Global Rights to Saniona Neurology Program as ATX0926 Moves Toward Clinic2M ago
Company AnnouncementsSaniona launches virtual R&D Day to spotlight SAN2668 for severe pediatric epilepsies5M ago
Company AnnouncementsSaniona shareholders block pay report as board pulls capital and incentive proposals5M ago
Company AnnouncementsSaniona Deepens Losses but Bolsters Cash as Pipeline Nears Clinic5M agoCompany AnnouncementsSaniona Publishes Comprehensive 2025 Annual Report Covering Operations, Financials and Governance6M ago
- Company AnnouncementsSaniona convenes 2026 AGM with governance and long-term incentive plan on agenda6M ago
Company AnnouncementsSaniona Steps Up Investor Outreach With Busy Spring Conference Schedule7M ago
Company AnnouncementsSaniona Shifts From Partnership-Driven Gains to Clinical Execution in 20258M ago- Company AnnouncementsSaniona Sets February Investor Call to Present Q4 Results and Pipeline Update8M ago
Company AnnouncementsSaniona Strengthens Leadership to Advance CNS Programs10M ago
